Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-17-058512
Filing Date
2017-11-14
Accepted
2017-11-13 19:01:36
Documents
59
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tv478386_10q.htm 10-Q 533386
2 EXHIBIT 10.1 tv478386_ex10-1.htm EX-10.1 9563
3 EXHIBIT 10.2 tv478386_ex10-2.htm EX-10.2 23418
4 EXHIBIT 31.1 tv478386_ex31-1.htm EX-31.1 6741
5 EXHIBIT 31.2 tv478386_ex31-2.htm EX-31.2 6978
6 EXHIBIT 32.1 tv478386_ex32-1.htm EX-32.1 3862
7 EXHIBIT 32.2 tv478386_ex32-2.htm EX-32.2 3868
8 GRAPHIC tv478386_ex10-2img01.jpg GRAPHIC 321089
  Complete submission text file 0001144204-17-058512.txt   4795639

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT capr-20170930.xml EX-101.INS 835674
10 XBRL TAXONOMY EXTENSION SCHEMA capr-20170930.xsd EX-101.SCH 50983
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE capr-20170930_cal.xml EX-101.CAL 35244
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE capr-20170930_def.xml EX-101.DEF 315710
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE capr-20170930_lab.xml EX-101.LAB 348401
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE capr-20170930_pre.xml EX-101.PRE 343151
Mailing Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211
Business Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211 (310) 358-3200
CAPRICOR THERAPEUTICS, INC. (Filer) CIK: 0001133869 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34058 | Film No.: 171197796
SIC: 2834 Pharmaceutical Preparations